selected scholarly activity
-
chapters
- General Management of the Hemodialysis Patient. 34-47. 2022
- Stroke and Atrial Fibrillation in Chronic Kidney Disease and Dialysis. 171-183. 2019
-
conferences
- The Association Between Intradialytic Symptom Clusters and Recovery Time in Patients Undergoing Maintenance Hemodialysis: An Exploratory Analysis. Canadian Journal of Kidney Health and Disease. 2024
- Characteristics of Relapse of Individuals With ANCA-Associated Vasculitis Enrolled in the PEXIVAS Trial. Journal of Rheumatology. 20-20. 2023
- The Effects of Initial Treatment on Relapse of ANCA-Associated Vasculitis in the PEXIVAS Trial. Journal of Rheumatology. 21-21. 2023
- Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration. American Journal of Kidney Diseases. 513-526. 2022
- Characteristics and Outcomes of Participants with and Without Diffuse Alveolar Hemorrhage in the Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (PEXIVAS) Trial. Arthritis & Rheumatology. 1057-1060. 2022
- Implementing a Patient-Reported Outcome Measure for Hemodialysis Patients in Routine Clinical Care. American Society of Nephrology. Clinical Journal. 1299-1309. 2020
- The Fragility of Statistically Significant Randomized Controlled Trials in Plastic Surgery. Plastic and Reconstructive Surgery. 1238-1245. 2019
- A new instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses. Trials. 2019
- ASSESSING SYMPTOM ASSESSMENT AND MANAGEMENT PROCESSES FOLLOWING THE ADMINISTRATION OF A PATIENT-REPORTED OUTCOME MEASURE TO HEMODIALYSIS PATIENTS IN ONTARIO. Nephrology Dialysis Transplantation. 584-584. 2019
- THE SAFETY AND EFFICACY OF GLUCOCORTICOIDS IN IGA NEPHROPATHY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Nephrology Dialysis Transplantation. 420-420. 2019
- THE EFFECT OF PLASMA EXCHANGE ON END-STAGE RENAL DISEASE AND DEATH IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2019
- THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2019
- UTILIZATION OF CANADIAN HEALTHCARE ADMINISTRATIVE DATABASES TO ACCURATELY IDENTIFY CASES OF ANCA-ASSOCIATED VASCULITIS. Rheumatology. 2019
- VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL. Rheumatology. 70-70. 2019
- The Effects of Plasma Exchange and Reduced-Dose Glucocorticoids during Remission-Induction for Treatment of Severe ANCA-Associated Vasculitis. Arthritis & Rheumatology. 2018
- Pharmacokinetics and Pharmacodynamics of Ionis-FXIRx, an Antisense Inhibitor of Factor XI, in Patients with End-Stage Renal Disease on Hemodialysis. Blood. 2017
- THE STEROID TAPERING IN ANCA VASCULITIS EVALUATION STUDY (STAVE) 2: A SYSTEMATIC REVIEW AND META-ANALYSIS. Nephrology Dialysis Transplantation. 147-147. 2017
- DEMOGRAPHIC CHARACTERISTICS OF JAPANESE PARTICIPANTS IN PEXIVAS AS COMPARED WITH REMIT-JAV. Rheumatology. 150-150. 2017
- PLASMA EXCHANGE AND GLUCOCORTICOID DOSING IN THE TREATMENT OF ANTI-NEUTROPHIL CYTOPLASM ANTIBODY ASSOCIATED VASCULITIS: BASELINE CHARACTERISTICS OF A RANDOMIZED CONTROLLED TRIAL (PEXIVAS). Rheumatology. 149-149. 2017
- TWO INTERNATIONAL MULTIREGIONAL INVESTIGATOR INITIATED CLINICAL TRIALS ON VASCULITIS: COLLABORATION WITH EUVAS, VCRC AND NATIONWIDE VASCULITIS STUDY GROUPS OF JAPAN. Rheumatology. 149-149. 2017
- Establishing Core Outcome Domains in Hemodialysis: Report of the Standardized Outcomes in Nephrology–Hemodialysis (SONG-HD) Consensus Workshop. American Journal of Kidney Diseases. 97-107. 2017
- EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS. Nephrology. 108-108. 2016
- THE EFFECTIVENESS OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL INTERVENTIONS IN IMPROVING RESTLESS LEGS SYNDROME SEVERITY AMONG PATIENTS ON DIALYSIS: A SYSTEMATIC REVIEW. Journal of Epidemiology and Community Health. A1.2-A1. 2015
- A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: “MYCYC”. On behalf of the European vasculitis study group. Presse Medicale. 678-679. 2013
- Predicting renal relapse with the histopathologic classification of ANCA-associated glomerulonephritis. Presse Medicale. 750-751. 2013
- Can Low-Molecular-Weight Heparin Be Safely Used as Prophylaxis Against Venous Thromboembolism in Critically Ill Patients with End-Stage Renal Disease? A Subgroup Analysis of the Protect Trial. American Journal of Hematology. S199-S200. 2012
- Optimal Definition for the Duration of Sustained Remission in ANCA-Associated Vasculitis. Arthritis and Rheumatism. S923-S924. 2011
- The prevalence of preoperative elevations in troponin T above the 99th percentile using the troponin T high sensitive assay in patients undergoing noncardiac surgery. Clinical Biochemistry. 1174-1174. 2011
- Alveolar haemorrhage in ANCA-AAV: an analysis of EUVAS trials. Clinical and Experimental Immunology. 113-113. 2011
- Measurement of health-related quality of life among patients with ANCA-AAV using the SF-36. Clinical and Experimental Immunology. 83-83. 2011
- PEXIVAS: design of an RCT of PLEX and GC dosing in the treatment of severe ANCA-AAV. Clinical and Experimental Immunology. 67-67. 2011
- Pulse versus daily oral CyP for induction of remission in ANCA-associated vasculitis. A European, multi-centre randomized controlled trial: long-term follow-up. Clinical and Experimental Immunology. 56-57. 2011
- Two-year follow-up results from a randomized trial of RTX versus CyP for ANCA-associated renal vasculitis: RITUXVAS. Clinical and Experimental Immunology. 57-58. 2011
- RITUXIMAB VERSUS CYCLOPHOSPHAMIDE IN ANCA ASSOCIATED RENAL VASCULITIS. Nephrology. 49-49. 2010
- Health-related quality of life in ANCA-associated vasculitis treated with a rituximab-based regimen vs cyclophosphamide. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 71-71. 2009
- Health-related quality of life in patients with ANCA-associated vasculitis: a pooled analysis of four randomized clinical trials. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 138-138. 2009
- Optimizing the Birmingham vasculitis activity scale to predict end-stage renal disease and death in ANCA-associated vasculitis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 140-140. 2009
- Plasma exchange in ANCA-associated vasculitis: a systematic review and meta-analysis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 75-75. 2009
- Predictors of long-term (>= 5 year) renal survival in 535 patients with ANCA-associated vasculitis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 150-150. 2009
- Randomized trial of mycophenolate mofetil vs azathioprine for maintenance therapy in ANCA-associated vasculitis (IMPROVE). APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 77-78. 2009
- Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 78-78. 2009
- The association between relapses of ANCA-associated vasculitis and the composite endpoint of end-stage renal disease or death. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 143-144. 2009
- A systematic review and meta-analysis of relapses in AAV: What is the effect of low-dose corticosteroids?. Nephrology Dialysis Transplantation. 282-282. 2007
- Long-term follow-up of relapsing/refractory ANCA associated vasculitis treated with the lymphocyte depleting antibody Alemtuzumab (CAMPATH-1H). Nephrology Dialysis Transplantation. 216-216. 2007
-
journal articles
- Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis: A Pilot Randomized Controlled Trial.. Journal of the American Society of Nephrology. 2024
- Authors' Reply: Proton Pump Inhibitors May Cause a Decline in eGFR by Inhibiting Organic Cation Transporter 2-Dependent Creatinine Secretion.. Journal of the American Society of Nephrology. 35:1614. 2024
- Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids. Arthritis & Rheumatology. 76:1431-1438. 2024
- Glucocorticoid Minimization in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An International Survey of Clinicians. Kidney Medicine. 6:100858-100858. 2024
- Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study. Nephrology Dialysis Transplantation. gfae156. 2024
- A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney International. 106:145-153. 2024
- The Effects of Pantoprazole on Kidney Outcomes. Journal of the American Society of Nephrology. 35:901-909. 2024
- Mental health and addiction service utilization among people living with chronic kidney disease. Nephrology Dialysis Transplantation. 39:1115-1124. 2024
- Development and external validation of the ‘Global Surgical-Site Infection’ (GloSSI) predictive model in adult patients undergoing gastrointestinal surgery. British Journal of Surgery. 111:znae129. 2024
- Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Results of an International Randomized Controlled Trial (PEXIVAS). American Journal of Respiratory and Critical Care Medicine. 209:1141-1151. 2024
- Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney International Supplements. 13:83-96. 2024
- Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team. Journal of the American Society of Nephrology. 35:229-231. 2024
- Characterizing Cluster-Based Frailty Phenotypes in a Multicenter Prospective Cohort of Kidney Transplant Candidates. Assistive Technology Research Series. 310:896-900. 2024
- Proteome-Wide Changes in Blood Biomarkers During Hemodialysis. Kidney International Reports. 9:177-181. 2024
- The Efficacy and Safety of Bisphosphonate Therapy for Osteopenia/Osteoporosis in Patients With Chronic Kidney Disease: A Systematic Review and Individual Patient-Level Meta-Analysis of Placebo-Controlled Randomized Trials.. Canadian Journal of Kidney Health and Disease. 11:20543581241283523. 2024
- The effect of micro-particle curcumin on chronic kidney disease progression: the MPAC-CKD randomized clinical trial. Nephrology Dialysis Transplantation. 38:2192-2200. 2023
- The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial. The Lancet Rheumatology. 5:e451-e460. 2023
- A step-by-step approach for selecting an optimal minimal important difference. The BMJ. 381:e073822-e073822. 2023
- An extension minimal important difference credibility item addressing construct proximity is a reliable alternative to the correlation item. Journal of Clinical Epidemiology. 157:46-52. 2023
- Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide. Current Opinion in Nephrology and Hypertension. 32:278-283. 2023
- Sex and Gender in Randomized Controlled Trials of Adults Receiving Maintenance Dialysis: A Meta-epidemiologic Study. American Journal of Kidney Diseases. 81:575-582.e1. 2023
- The Effect of Chronic Kidney Disease or End-stage Kidney Disease on Perioperative Outcomes and Healthcare Utilization in Patients Undergoing Bariatric Surgery. Obesity Surgery. 33:1476-1485. 2023
- Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan. Kidney International Reports. 8:860-870. 2023
- Patient views regarding cannabis use in chronic kidney disease and kidney failure: a survey study. Nephrology Dialysis Transplantation. 38:922-931. 2023
- High-Sensitivity Cardiac Troponin I Thresholds to Identify Myocardial Injury After Noncardiac Surgery: A Cohort Study. Canadian Journal of Cardiology. 39:311-318. 2023
- Plasma Exchange for ANCA-Associated Vasculitis: An International Survey of Patient Preferences. Kidney Medicine. 5:100595-100595. 2023
- “You need a team”: perspectives on interdisciplinary symptom management using patient-reported outcome measures in hemodialysis care—a qualitative study. Journal of Patient-Reported Outcomes. 7:3. 2023
- Health Services Use and Outcomes for Hospital Admissions With a Major Cardiovascular Event Recorded in Health Care Administrative Data in Patients Receiving Maintenance Hemodialysis: A Retrospective Cohort Study. Canadian Journal of Kidney Health and Disease. 10:205435812311657-205435812311657. 2023
- Association of abnormal electrocardiograph metrics with prolonged recovery time in incident hemodialysis patients. BMC Nephrology. 23:46. 2022
- How the Routine Use of Patient-Reported Outcome Measures for Hemodialysis Care Influences Patient-Clinician Communication. American Society of Nephrology. Clinical Journal. 17:1631-1645. 2022
- INTERBLEED: Design of an International Study of Risk Factors for Gastrointestinal Bleeding and Cardiovascular Events After Gastrointestinal Bleeding. CJC OPEN. 4:996-1005. 2022
- Patient Views Regarding Cannabis Use in CKD and Kidney Failure: A Survey Study. Journal of the American Society of Nephrology. 33:695-695. 2022
- Personalised cooler dialysate for patients receiving maintenance haemodialysis (MyTEMP): a pragmatic, cluster-randomised trial. The Lancet. 400:1693-1703. 2022
- Sex and Gender Considerations in Randomized Controlled Trials in Adults Receiving Chronic Dialysis: A Meta-Epidemiologic Study. Journal of the American Society of Nephrology. 33:266-266. 2022
- The Impact of Gender Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis. Journal of the American Society of Nephrology. 33:567-567. 2022
- Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health Technology Assessment. 26:1-60. 2022
- The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function. American Society of Nephrology. Clinical Journal. 17:1305-1315. 2022
- Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD. American Society of Nephrology. Clinical Journal. 17:1247-1250. 2022
- The Sound of Interconnectivity; The European Vasculitis Society 2022 Report. Kidney International Reports. 7:1745-1757. 2022
- Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis. Canadian Journal of Surgery. 65:E450-E459. 2022
- Impact of Bioelectrical Impedance–Guided Fluid Management and Vitamin D Supplementation on Left Ventricular Mass in Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial. American Journal of Kidney Diseases. 79:820-831. 2022
- Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study. CKJ: Clinical Kidney Journal. 15:681-692. 2022
- Plasma Exchange in ANCA-Associated Vasculitis: For Whom (If Any)?. Journal of the American Society of Nephrology. 33:465-466. 2022
- Targeting the opioid pathway for the treatment of chronic kidney disease‐associated pruritus: a systematic review and meta‐analysis of randomized controlled trials. British Journal of Dermatology. 186:575-577. 2022
- Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline. The BMJ. 376:e064597-e064597. 2022
- The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis. The BMJ. 376:e064604-e064604. 2022
- A systematic survey identified methodological issues in studies estimating anchor-based minimal important differences in patient-reported outcomes. Journal of Clinical Epidemiology. 142:144-151. 2022
- Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review. BMJ Open. 12:e050507-e050507. 2022
- Mapping the Edmonton Symptom Assessment System-Revised: Renal to the EQ-5D-5L in patients with chronic kidney disease. Quality of Life Research. 31:567-577. 2022
- Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXIRx in Patients With ESRD. Kidney International Reports. 7:200-209. 2022
- Improvement of kidney function in patients with chronic kidney disease and severe obesity after bariatric surgery: A systematic review and meta‐analysis. Nephrology. 27:44-56. 2022
- Burden of mental health symptoms and perceptions of their management in in-centre hemodialysis care: a mixed methods study. Journal of Patient-Reported Outcomes. 5:111. 2021
- High-Throughput Analysis of Changes in Protein Biomarkers During Hemodialysis. Journal of the American Society of Nephrology. 32:317-317. 2021
- Preferences Regarding Treatment with Plasma Exchange for ANCA-Associated Vasculitis: An International Patient Survey. Journal of the American Society of Nephrology. 32:507-507. 2021
- Use of Critical Items in Determining Point-of-Care Ultrasound Competence. Evaluation and the Health Professions. 44:220-225. 2021
- Predicting Myocardial Injury and Other Cardiac Complications After Elective Noncardiac Surgery with the Revised Cardiac Risk Index: The VISION Study. Canadian Journal of Cardiology. 37:1215-1224. 2021
- Prevalence of Frailty in Patients Referred to the Kidney Transplant Waitlist. Kidney360. 2:1287-1295. 2021
- Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial. Contemporary Clinical Trials. 107:106466-106466. 2021
- SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline. The BMJ. 373:n1091-n1091. 2021
- Comparing Renal Replacement Therapy Modalities in Critically Ill Patients With Acute Kidney Injury: A Systematic Review and Network Meta-Analysis. Critical Care Explorations. 3:e0399-e0399. 2021
- POS-166 THE EFFECTS OF PLASMA EXCHANGE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS. Kidney International Reports. 6:S68-S68. 2021
- In Search of the Optimal Target for Phosphate Control: Episode 1. Journal of the American Society of Nephrology. 32:526-528. 2021
- Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey. Journal of Pain and Symptom Management. 61:237-245.e2. 2021
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. The BMJ. 372:m4573-m4573. 2021
- Variability in Cardiac Biomarkers during Hemodialysis: A Prospective Cohort Study. Clinical Chemistry. 67:308-316. 2021
- Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial. PLoS ONE. 16:e0248567-e0248567. 2021
- Incidence and Outcomes of Acute Kidney Injury in Patients Admitted to Hospital With COVID-19: A Retrospective Cohort Study. Canadian Journal of Kidney Health and Disease. 8:205435812110277-205435812110277. 2021
- MyTEMP: Statistical Analysis Plan of a Registry-Based, Cluster-Randomized Clinical Trial. Canadian Journal of Kidney Health and Disease. 8:205435812110411-205435812110411. 2021
- The WISHED Randomized Controlled Trial: Impact of an Interactive Health Communication Application on Home Dialysis Use in People With Chronic Kidney Disease. Canadian Journal of Kidney Health and Disease. 8:205435812110196-205435812110196. 2021
- A cluster randomized controlled trial for the Evaluation of routinely Measured PATient reported outcomes in HemodialYsis care (EMPATHY): a study protocol. BMC Health Services Research. 20:731. 2020
- Prerandomization run-in periods in randomized controlled trials of chronic diseases: a methodological study. Journal of Clinical Epidemiology. 128:148-156. 2020
- Fragility of clinical trials across research fields: A synthesis of methodological reviews. Contemporary Clinical Trials. 97:106151-106151. 2020
- Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses. CANADIAN MEDICAL ASSOCIATION JOURNAL. 192:E901-E906. 2020
- Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Joneset al’by Vandergheynstet al. Annals of the Rheumatic Diseases. 79:e101-e101. 2020
- Erratum to “A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses” [J Clin Epidemiol. 2019;113:159-67]. Journal of Clinical Epidemiology. 123:189-189. 2020
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. New England Journal of Medicine. 382:2168-2169. 2020
- Association Between Myocardial Injury and Cardiovascular Outcomes of Orthopaedic Surgery. Journal of Bone and Joint Surgery. American volume. 102:880-888. 2020
- The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease. Nephrology Dialysis Transplantation. 35:782-789. 2020
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. New England Journal of Medicine. 382:622-631. 2020
- Preoperative N-Terminal Pro–B-Type Natriuretic Peptide and Cardiovascular Events After Noncardiac Surgery. ACP journal club. 172:96-96. 2020
- Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study. Canadian Journal of Kidney Health and Disease. 7:205435812095743-205435812095743. 2020
- Major Outcomes With Personalized Dialysate TEMPerature (MyTEMP): Rationale and Design of a Pragmatic, Registry-Based, Cluster Randomized Controlled Trial. Canadian Journal of Kidney Health and Disease. 7:205435811988798-205435811988798. 2020
- Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 97:42-61. 2020
- The DIalysis Symptom COntrol-Restless Legs Syndrome (DISCO-RLS) Trial: A Protocol for a Randomized, Crossover, Placebo-Controlled Blinded Trial. Canadian Journal of Kidney Health and Disease. 7:205435812096895-205435812096895. 2020
- A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses. Journal of Clinical Epidemiology. 113:159-167. 2019
- Screening questions for the diagnosis of restless legs syndrome in hemodialysis. CKJ: Clinical Kidney Journal. 12:559-563. 2019
- Association between complications and death within 30 days after noncardiac surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 191:E830-E837. 2019
- FP687THE ASSOCIATION BETWEEN INTRA-DIALYTIC SYMPTOM CLUSTERS AND RECOVERY TIME IN PATIENTS UNDERGOING CHRONIC HEMODIALYSIS: AN EXPLORATORY ANALYSIS. Nephrology Dialysis Transplantation. 34:gfz106.fp687. 2019
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 95:1304-1317. 2019
- SP677IMPLEMENTING A PATIENT-REPORTED OUTCOME MEASURE FOR HEMODIALYSIS PATIENTS IN ROUTINE CLINICAL CARE: PERSPECTIVES OF PATIENTS AND CLINICIANS. Nephrology Dialysis Transplantation. 34:gfz103.sp677. 2019
- Change in albuminuria as a surrogate endpoint in chronic kidney disease. The Lancet Diabetes and Endocrinology. 7:335-335. 2019
- Bioavailability of oral curcumin. CANADIAN MEDICAL ASSOCIATION JOURNAL. 191:E428-E428. 2019
- Long-term low-dose maintenance glucocorticoids in ANCA vasculitis. Clinical Nephrology. 91:200-205. 2019
- Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints. European Heart Journal. 40:880-886. 2019
- Effect of methylprednisolone on acute kidney injury in patients undergoing cardiac surgery with a cardiopulmonary bypass pump: a randomized controlled trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 191:E247-E256. 2019
- 160. VERITAS: VASCULITIS: EFFECTS OF REMISSION MAINTENANCE THERAPIES ON RELAPSE AND SIDE EFFECTS ON PATIENT PREFERENCES: A STUDY PROTOCOL. Rheumatology. 58:kez059.037. 2019
- A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease. Clinical Chemistry. 65:427-436. 2019
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial. Annals of the Rheumatic Diseases. 78:399-405. 2019
- Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey. Canadian Journal of Kidney Health and Disease. 6:205435811882194-205435811882194. 2019
- Cultivating Innovative Pragmatic Cluster-Randomized Registry Trials Embedded in Hemodialysis Care: Workshop Proceedings From 2018. Canadian Journal of Kidney Health and Disease. 6:205435811989439-205435811989439. 2019
- Leveraging pragmatic clinical trial design to advance phosphate management in end-stage renal disease. Current Opinion in Nephrology and Hypertension. 28:34-39. 2019
- Renal relapse in antineutrophil cytoplasmic autoantibody-associated vasculitis: unpredictable, but predictive of renal outcome. Rheumatology. 58:103-109. 2019
- Single Questions for the Screening of Anxiety and Depression in Hemodialysis. Canadian Journal of Kidney Health and Disease. 6:205435811882544-205435811882544. 2019
- Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model. Thrombosis Research. 172:181-187. 2018
- Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial. CANADIAN MEDICAL ASSOCIATION JOURNAL. 190:E1273-E1280. 2018
- Blood HER2 and Uromodulin as Causal Mediators of CKD. Journal of the American Society of Nephrology. 29:1326-1335. 2018
- HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study. American Journal of Kidney Diseases. 71:166-172. 2018
- Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function. Canadian Journal of Kidney Health and Disease. 5:205435811774953-205435811774953. 2018
- Canadians seeking solutions and innovations to overcome chronic kidney disease (Can-SOLVE CKD): Form and function. Canadian Journal of Kidney Health and Disease. 5. 2018
- Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial. PLoS ONE. 13:e0198285-e0198285. 2018
- Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial. Canadian Journal of Kidney Health and Disease. 5:205435811881308-205435811881308. 2018
- Barriers and facilitators to healthcare professional behaviour change in clinical trials using the Theoretical Domains Framework: a case study of a trial of individualized temperature-reduced haemodialysis. Trials. 18:227. 2017
- Discrimination and Calibration of Clinical Prediction Models. Journal of the American Medical Association (JAMA). 318:1377-1377. 2017
- Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International. 92:297-305. 2017
- The Fragility of Statistically Significant Findings From Randomized Trials in Sports Surgery: A Systematic Survey. American Journal of Sports Medicine. 45:2164-2170. 2017
- Two phosphAte taRGets in End-stage renal disease Trial (TARGET): A Randomized Controlled Trial. American Society of Nephrology. Clinical Journal. 12:965-973. 2017
- Association of Postoperative High-Sensitivity Troponin Levels With Myocardial Injury and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. Journal of the American Medical Association (JAMA). 317:1642-1642. 2017
- When is a meta-analysis conclusive? A guide to Trial Sequential Analysis with an example of remote ischemic preconditioning for renoprotection in patients undergoing cardiac surgery. Nephrology Dialysis Transplantation. 32:ii23-ii30. 2017
- External validation of the Revised Cardiac Risk Index and update of its renal variable to predict 30-day risk of major cardiac complications after non-cardiac surgery: rationale and plan for analyses of the VISION study. BMJ Open. 7:e013510-e013510. 2017
- Plasmapheresis for the treatment of kidney diseases. Kidney International. 90:974-984. 2016
- ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse. PLoS ONE. 11:e0165402-e0165402. 2016
- The WISHED Trial: Implementation of an Interactive Health Communication Application for Patients with Chronic Kidney Disease. Canadian Journal of Kidney Health and Disease. 3:120-120. 2016
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Annals of the Rheumatic Diseases. 74:1178-1182. 2015
- Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts. Clinical and Experimental Rheumatology. 33:S77-S83. 2015
- Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction. Kidney International. 87:370-381. 2015
- CanVasc Recommendations for the Management of Antineutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitides – Executive Summary. Canadian Journal of Kidney Health and Disease. 2:78-78. 2015
- Establishing a Canadian National Clinical Trials Network for Kidney Disease: Proceedings of a Planning Workshop. Canadian Journal of Kidney Health and Disease. 2:80-80. 2015
- Perioperative Aspirin and Clonidine and Risk of Acute Kidney Injury. Journal of the American Medical Association (JAMA). 312:2254-2254. 2014
- Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysis. BMC Nephrology. 15:53. 2014
- Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease. CKJ: Clinical Kidney Journal. 7:562-568. 2014
- The impact of patient preference on dialysis modality and hemodialysis vascular access. BMC Nephrology. 15:38. 2014
- Kidney Function After Off-Pump or On-Pump Coronary Artery Bypass Graft Surgery. Journal of the American Medical Association (JAMA). 311:2191-2191. 2014
- Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Glomerulonephritis in Adults. American Journal of Kidney Diseases. 63:363-377. 2014
- Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis: Management of Nephrotic Syndrome in Children. American Journal of Kidney Diseases. 63:354-362. 2014
- Economic Evaluation of Frequent Home Nocturnal Hemodialysis Based on a Randomized Controlled Trial. Journal of the American Society of Nephrology. 25:587-594. 2014
- Myocardial Injury after Noncardiac Surgery. Anesthesiology. 120:564-578. 2014
- Steroids In caRdiac Surgery (SIRS) trial: acute kidney injury substudy protocol of an international randomised controlled trial. BMJ Open. 4:e004842-e004842. 2014
- Aspirin and clonidine in non-cardiac surgery: acute kidney injury substudy protocol of the Perioperative Ischaemic Evaluation (POISE) 2 randomised controlled trial. BMJ Open. 4:e004886-e004886. 2014
- Establishing a National Knowledge Translation and Generation Network in Kidney Disease: The CAnadian KidNey KNowledge TraNslation and GEneration NeTwork. Canadian Journal of Kidney Health and Disease. 1:2-2. 2014
- The Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis (SIMPL) Pilot Trial. Canadian Journal of Kidney Health and Disease. 1:30-30. 2014
- The Risk of Perioperative Bleeding in Patients With Chronic Kidney Disease. Annals of Surgery. 258:901-913. 2013
- Estimated GFR Reporting Influences Recommendations for Dialysis Initiation. Journal of the American Society of Nephrology. 24:1737-1742. 2013
- The Association Between Perioperative Hemoglobin and Acute Kidney Injury in Patients Having Noncardiac Surgery. Anesthesia and Analgesia. 117:924-931. 2013
- Progressive multifocal leukoencephalopathy with gastrointestinal disease in a pediatric kidney transplant recipient. Pediatric Transplantation. 17:E119-E124. 2013
- European Vasculitis Study (EUVAS) investigators: Intravenous cyclophosphamide and plasmapheresis in dialysis-dependent ANCA-associated vasculitis (vol 8, pg 219, 2013). American Society of Nephrology. Clinical Journal. 8:701-701. 2013
- Intravenous Cyclophosphamide and Plasmapheresis in Dialysis-Dependent ANCA-Associated Vasculitis. American Society of Nephrology. Clinical Journal. 8:219-224. 2013
- Association of Calcium, Phosphate and Parathyroid Hormone with Renal Allograft Function: A Retrospective Cohort Study. American Journal of Nephrology. 37:339-345. 2013
- Increased cardiovascular risk after pre‐eclampsia in women with dysglycaemia. Diabetic Medicine. 30:e1-e7. 2013
- Reply. Arthritis and Rheumatism. 64:3058-3058. 2012
- Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Canadian Journal of Anaesthesia. 59:861-870. 2012
- Secular trends in acute dialysis after elective major surgery — 1995 to 2009. CANADIAN MEDICAL ASSOCIATION JOURNAL. 184:1237-1245. 2012
- Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrology Dialysis Transplantation. 27:2761-2767. 2012
- Error in Viewpoint in: Statin Therapy for Healthy Men Identified as ‘Increased Risk,’. Journal of the American Medical Association (JAMA). 307:2590-2590. 2012
- Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery. Journal of the American Medical Association (JAMA). 307:2295-2295. 2012
- Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury—A prospective multicenter observational study. Journal of Critical Care. 27:268-275. 2012
- Tubular Lesions Predict Renal Outcome in Antineutrophil Cytoplasmic Antibody–Associated Glomerulonephritis after Rituximab Therapy. Journal of the American Society of Nephrology. 23:313-321. 2012
- Coronary Artery Bypass Grafting Surgery Off- or On-pump Revascularisation Study (CORONARY): kidney substudy analytic protocol of an international randomised controlled trial. BMJ Open. 2:e001080-e001080. 2012
- Peritoneal Dialysis Patients with Critical Illness: Insurance May be Hard to Come By. Advances in peritoneal dialysis. Conference on Peritoneal Dialysis. 32:7-9. 2012
- Statin Use Associates with a Lower Incidence of Acute Kidney Injury after Major Elective Surgery. Journal of the American Society of Nephrology. 22:939-946. 2011
- The Effect of Nocturnal and Conventional Hemodialysis on Markers of Nutritional Status: Results From a Randomized Trial. Journal of Renal Nutrition. 21:271-276. 2011
- Preventing Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis—Reply. Journal of the American Medical Association (JAMA). 305:996-996. 2011
- An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study.. Open Medicine. 5:e193-e200. 2011
- The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis—A Simulation Study. PLoS ONE. 6:e25491-e25491. 2011
- Association between routine and standardized blood pressure measurements and left ventricular hypertrophy among patients on hemodialysis. BMC Nephrology. 11:13. 2010
- Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease. ACP journal club. 153:JC5-JC5. 2010
- Early and late initiation of dialysis did not differ for reduction of all-cause mortality in stage 5 chronic kidney disease. Annals of Internal Medicine. 153. 2010
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis. New England Journal of Medicine. 363:211-220. 2010
- Kidney Disease After Preeclampsia: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases. 55:1026-1039. 2010
- Generalized pruritic eruption in a patient with chronic kidney disease. Dermatology Online Journal. 16:10. 2010
- The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized‐controlled trial. Hemodialysis International. 14:174-181. 2010
- Ascorbic Acid for Anemia Management in Hemodialysis Patients: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases. 54:1089-1097. 2009
- Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney International. 75:542-549. 2009
- Monoclonal gammopathy and glomerulopathy associated with chronic lymphocytic leukemia. Nature Reviews Nephrology. 5:54-58. 2009
- Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease. Journal of the American Society of Nephrology. 18:993-999. 2007
- The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: Rationale and study design of a randomized controlled pilot study. BMC Nephrology. 7:2. 2006
- Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohort. Nephrology Dialysis Transplantation. 21:93-100. 2006
- Reply from the Authors. Kidney International. 68:2914-2914. 2005
- A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney International. 67:1500-1508. 2005